Market Research Report
North America Orthobiologics Market Forecast 2019-2027
|Published by||Inkwood Research||Product code||492791|
|Published||Content info||82 Pages
Delivery time: 2-3 business days
|North America Orthobiologics Market Forecast 2019-2027|
|Published: March 20, 2019||Content info: 82 Pages||
North America orthobiologics market finds its application in spinal fusion, trauma repair, reconstructive surgery, tendon and ligament repair, and others. The orthobiologics market in North America is growing at a CAGR of 5.10% (in million $) owing due to the growth in geriatric population coupled with the rise in disposable income paving the way for the market in this region.
The alertness about orthobiologics is a lashing force for surgeons to switch from mechanical implants to biological implants. The market's increase since 2012 is due to increased research and rising demand for the products due to their benefits.
Also, the United States orthobiologics market has the largest share in North America, and it's expected to continue growing. The Canadian region will also have growth driven by increasing research investments thereby helping the market to develop in this region.
However, the high costs of spinal and other orthopedic surgeries are one of the major factors which are hampering the growth of the market in forecast period 2019-2027.
Integra Lifesciences Holding Corporation, Sanofi, Stryker Corporation, Zimmer Biomet Inc., Nuvasive Inc., Depuy Inc. (Acquired by Johnson and Johnson), Medtronic Inc., Smith & Nephew Plc, RTI Surgical, Allosource, Exactech Inc., Amedica Corporation, Baxter International Inc., AAP Implantate AG and Conmed Corporation are the companies mentioned in the report.